TY  - GEN
AU  - Knopman,D
AU  - Patterson,M
TI  - An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients
SN  - 0893-0341
PY  - 2001///0927
KW  - Administration, Oral
KW  - Aged
KW  - Aged, 80 and over
KW  - Alzheimer Disease
KW  - drug therapy
KW  - Betaine
KW  - adverse effects
KW  - Cognition Disorders
KW  - Disease Progression
KW  - Female
KW  - Gastrointestinal Agents
KW  - Homocysteine
KW  - metabolism
KW  - Humans
KW  - Male
KW  - Mental Status Schedule
KW  - Middle Aged
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/00002093-200107000-00008
ER  -